Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
3.6 Literatur
Agarwal SK, Ghosh PK, Gupta D (1995) Cardiac surgery and cold-reactive proteins. Ann Thorac Surg 60:1143–1150
Aggarwal A, Malkovska V, Catlett JP et al. (2004) Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage. Thromb J 2:9
Aldea GS, Soltow LO, Chandler WL et al. (2002) Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 123:742–755
Baltalari A, Keskin A, Sirin BH (2000) Warm heart surgery for the patient with cold agglutinins. The Internet Journal of Thoracic and Cardiovascular Surgery, Vol. 3, No 2
Beierlein W, Scheule M, Dietrich W et al. (2005) Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg 79:741–748
Boldt J, Knothe C, Welters I et al. (1996) Normothermic versus hypo thermic cardiopulmonary bypass: do changes in coagulation differ? Ann Thorac Surg 62:130–135
Carr JA, Silverman N (1999) The heparin-protamine interaction. A review. J Cardiovasc Surg (Torino) 40:659–666
Cattaneo M, Harris AS, Stromberg U et al. (1995) The effect of desmopressin on reducing blood loss in cardiac surgery — a meta-analysis of double-blind, placebo-controlled trials. Thromb Haemost 74:1064–1070
Chung JH, Gikakis N, Rao AK et al. (1996) Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 93:2014–2018
de Haan J, Boonstra PW, Monnink SH et al. (1995) Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 59:901–907
Despotis GJ, Filos KS, Zoys TN et al. (1996) Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 82:13–21
Diaz JH, Cooper ES, Ochsner Jl (1984) Cardiac surgery in patients with cold autoimmune diseases. Anesth Analg 63:349–352
Dietrich W, Thuermel K, Heyde S, Busley R, Berger K (2005) Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness. J Cardiothorac Vasc Anesth 19:589–596
Dilthey G, Dietrich W, Spannagl M et al. (1993) Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Vasc Anesth 7:425–430
Franke UF, Korsch S, Wittwer T, Albes JM, Wippermann J, Kaluza M et al. (2003) Intermittent antegrade warm myocardial protection compared to intermittent cold blood cardioplegia in elective coronary surgery — do we have to change? Eur J Cardiothoracic Surg 23(3):341–346
Herbertson M (2004) Recombinant activated factor VII in cardiac surgery. Blood Coagul Fibrinolysis 15(Suppl 1):S31–S32
Holloway DS, Summaria L, Sandesara J et al. (1988) Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 59:62–67
Laupacis A, Fergusson D (1997) Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 85:1258–1267
Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten (2003) Vorstand und Wissenschaftlicher Beirat der Bundesärztekammer. Deutscher Ärzte-Verlag, Köln
Levy JH, Tanaka KA (2003) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75:S715–S720
Levy JH, Tanaka KA, Steiner ME (2005) Evaluation and management of bleeding during cardiac surgery. Curr Hematol Rep 4(5):368–372
Litmathe J, Boeken U, Feindt P, Gams E (2003) Predictors of homologous blood transfusion for patients undergoing open heart surgery. Thorac Cardiovasc Surg 51:17–21
Mahdy AM, Webster NR (2004) Perioperative systemic haemostatic agents. Br J Anaesth 93:842–858
McDOnald MB, McMillan J (2005) Predicting blood usage in cardiac surgery-the transfusion predictor product. J Extra Corpor Technol 37(2):157–160
Michelson AD, MacGregor H, Barnard MR et al. (1994) Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 71:633–640
Mochizuki T, Olson PJ, Szlam F et al. (1998) Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 87:781–785
Munoz JJ, Birkmeyer NJ, Birkmeyer JD et al. (1999) Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. Circulation 99:81–89
Murphy GJ, Ascione R, Angelini GD (2004) Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur Heart J 25:2077–2085
Norfolk DR, Ancliffe PJ, Contreras M et al. (1998) Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27–28 November 1997. Synopsis of background papers. Br J Haematol 101:609–617
Parr KG, Patel MA, Dekker R et al. (2003) Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth 17:176–181
Peyrou V, Lormeau JC, Herault JP et al. (1999) Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 81:400–406
Schmidt PJ (1985) Cold agglutinins and hypothermia. Arch Intern Med 145:578–579
Sellman M, Intonti MA, Ivert T (1997) Reoperations for bleeding after coronary artery bypass procedures during 25 years. Eur J Cardiothorac Surg 11:521–527
Stanworth SJ, Brunskill SJ, Hyde CJ et al. (2004) Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126:139–152
Teufelsbauer H, Proidl S, Havel M et al. (1992) Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 68:250–252
Uijttewaal WS, Nijhof EJ, Bronkhorst PJ et al. (1993) Near-wall excess of platelets induced by lateral migration of erythrocytes in flowing blood. Am J Physiol 264:H1239–H1244
Unsworth-White MJ, Herriot A, Valencia O et al. (1987) Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 59:664–667
Valeri CR, Feingold H, Cassidy G et al. (1987) Hypothermia-induced reversible platelet dysfunction. Ann Surg 205:175–181
Valles J, Santos MT, Aznar J et al. (1991) Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 78:154–162
von Heymann C, Schoenfeld H, Sander M et al. (2005) Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: a rationale for the use of coagulation factor concentrates? Heart Surg Forum 8:E39–41
Weerasinghe A, Taylor KM (1998) The platelet in cardiopulmonary bypass. Ann Thorac Surg 66:2145–2152
Wells PS (2002) Safety and efficacy of methods for reducing perioperative allogeneic transfusion: a critical review of the literature. Am J Ther 9:377–388
Ziats NP, Pankowsky DA, Tierney BP et al. (1990) Adsorption of Hageman factor (factor XII) and other human plasma proteins to biomedical polymers. J Lab Clin Med 116:687–696
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
Sucker, C. (2006). Perioperative Hämostasestörungen und Transfusion in der Kardiochirurgie. In: Feindt, P., Harig, F., Weyand, M. (eds) Empfehlungen zum Einsatz und zur Verwendung der Herz-Lungen-Maschine. Steinkopff. https://doi.org/10.1007/3-7985-1646-4_4
Download citation
DOI: https://doi.org/10.1007/3-7985-1646-4_4
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1504-8
Online ISBN: 978-3-7985-1646-5
eBook Packages: Medicine (German Language)